Thomas John Manley

Person

Seattle, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of reducing side effects of anti-CD30 antibody drug conjuga...
- Patent number 11,795,229
- Issue date Oct 24, 2023
- Seattle Genetics, Inc.
- Thomas Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Dosage and administration of non-fucosylated anti-CD40 antibodies
- Patent number 11,202,827
- Issue date Dec 21, 2021
- SEAGEN INC.
- Shyra Gardai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
METHODS OF REDUCING SIDE EFFECTS OF ANTI-CD30 ANTIBODY DRUG CONJUGA...
- Publication number 20240245753
- Publication date Jul 25, 2024
- Seagen Inc.
- Thomas Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
- Publication number 20240075135
- Publication date Mar 7, 2024
- Seagen Inc.
- Shyra Gardai
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
- Publication number 20230201343
- Publication date Jun 29, 2023
- Seagen Inc.
- Shyra Gardai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Anti-CD30 ADC, Anti-PD-1 and Chemotherapeutic for Treat...
- Publication number 20220347313
- Publication date Nov 3, 2022
- SEAGEN, INC.
- Thomas Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
- Publication number 20220249662
- Publication date Aug 11, 2022
- Seagen Inc.
- Shyra Gardai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF REDUCING SIDE EFFECTS OF ANTI-CD30 ANTIBODY DRUG CONJUGA...
- Publication number 20220226439
- Publication date Jul 21, 2022
- Seagen Inc.
- Thomas Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of Reducing Side Effects of Anti-CD30 Antibody Drug Conjuga...
- Publication number 20210221901
- Publication date Jul 22, 2021
- Seattle Genetics, Inc.
- Thomas Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods of Treating Peripheral T Cell Lymphoma Using Anti-CD30 Anti...
- Publication number 20200102399
- Publication date Apr 2, 2020
- Seattle Genetics, Inc.
- Thomas Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES
- Publication number 20170137528
- Publication date May 18, 2017
- Seattle Genetics, Inc.
- Shyra Gardai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Thomas John Manley

Person

Patents Grantslast 30 patents

Methods of reducing side effects of anti-CD30 antibody drug conjuga...

Dosage and administration of non-fucosylated anti-CD40 antibodies

Patents Applicationslast 30 patents

METHODS OF REDUCING SIDE EFFECTS OF ANTI-CD30 ANTIBODY DRUG CONJUGA...

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

Combination Anti-CD30 ADC, Anti-PD-1 and Chemotherapeutic for Treat...

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES

METHODS OF REDUCING SIDE EFFECTS OF ANTI-CD30 ANTIBODY DRUG CONJUGA...

Methods of Reducing Side Effects of Anti-CD30 Antibody Drug Conjuga...

Methods of Treating Peripheral T Cell Lymphoma Using Anti-CD30 Anti...

DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIES